Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152M
-
Number of holders
-
534
-
Total 13F shares, excl. options
-
37.2M
-
Shares change
-
-343K
-
Total reported value, excl. options
-
$12.9B
-
Value change
-
-$180M
-
Put/Call ratio
-
0.5
-
Number of buys
-
230
-
Number of sells
-
-281
-
Price
-
$346.64
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q2 2022
608 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q2 2022.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 534 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.2M shares
of 152M outstanding shares and own 24.43% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (4.46M shares), BlackRock Inc. (4.29M shares), STATE STREET CORP (1.57M shares), BAMCO INC /NY/ (1.45M shares), Select Equity Group, L.P. (1.32M shares), Neuberger Berman Group LLC (1.05M shares), BROWN CAPITAL MANAGEMENT LLC (840K shares), GEODE CAPITAL MANAGEMENT, LLC (787K shares), Winslow Capital Management, LLC (775K shares), and DF DENT & CO INC (684K shares).
This table shows the top 534 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.